189 related articles for article (PubMed ID: 31777472)
1. Contrast-Enhanced MRI Texture Parameters as Potential Prognostic Factors for Primary Central Nervous System Lymphoma Patients Receiving High-Dose Methotrexate-Based Chemotherapy.
Chen C; Zhuo H; Wei X; Ma X
Contrast Media Mol Imaging; 2019; 2019():5481491. PubMed ID: 31777472
[TBL] [Abstract][Full Text] [Related]
2. Contrast-Enhanced CT Texture Analysis: a New Set of Predictive Factors for Small Cell Lung Cancer.
Chen C; Ou X; Li H; Zhao Y; Zhao F; Zhou S; Ma X
Mol Imaging Biol; 2020 Jun; 22(3):745-751. PubMed ID: 31429049
[TBL] [Abstract][Full Text] [Related]
3. Magnetic resonance texture analysis utility in differentiating intraparenchymal neurosarcoidosis from primary central nervous system lymphoma: a preliminary analysis.
Bathla G; Soni N; Endozo R; Ganeshan B
Neuroradiol J; 2019 Jun; 32(3):203-209. PubMed ID: 30789057
[TBL] [Abstract][Full Text] [Related]
4. Texture Analysis of T1-Weighted Contrast-Enhanced Magnetic Resonance Imaging Potentially Predicts Outcomes of Patients with Non-Wingless-Type/Non-Sonic Hedgehog Medulloblastoma.
Li J; Chen C; Fu R; Zhang Y; Fan Y; Xu J; Cen Y
World Neurosurg; 2020 May; 137():e27-e33. PubMed ID: 31589984
[TBL] [Abstract][Full Text] [Related]
5. Pretreatment dynamic contrast-enhanced MRI biomarkers correlate with progression-free survival in primary central nervous system lymphoma.
Hatzoglou V; Oh JH; Buck O; Lin X; Lee M; Shukla-Dave A; Young RJ; Peck KK; Vachha B; Holodny AI; Grommes C
J Neurooncol; 2018 Nov; 140(2):351-358. PubMed ID: 30073640
[TBL] [Abstract][Full Text] [Related]
6. Comparison between Glioblastoma and Primary Central Nervous System Lymphoma Using MR Image-based Texture Analysis.
Kunimatsu A; Kunimatsu N; Kamiya K; Watadani T; Mori H; Abe O
Magn Reson Med Sci; 2018 Jan; 17(1):50-57. PubMed ID: 28638001
[TBL] [Abstract][Full Text] [Related]
7. Is deep brain involvement in intracranial primary central nervous system lymphoma of importance for penetration of chemotherapeutic agents?
Meling TR; Latysheva A; Da Broi M; Jahr G; Holte H; Beiske K; Emblem KE
Neuroradiology; 2018 Jul; 60(7):703-713. PubMed ID: 29804159
[TBL] [Abstract][Full Text] [Related]
8. Glioblastoma and primary central nervous system lymphoma: Preoperative differentiation by using MRI-based 3D texture analysis.
Xiao DD; Yan PF; Wang YX; Osman MS; Zhao HY
Clin Neurol Neurosurg; 2018 Oct; 173():84-90. PubMed ID: 30092408
[TBL] [Abstract][Full Text] [Related]
9. Machine Learning-based Texture Analysis of Contrast-enhanced MR Imaging to Differentiate between Glioblastoma and Primary Central Nervous System Lymphoma.
Kunimatsu A; Kunimatsu N; Yasaka K; Akai H; Kamiya K; Watadani T; Mori H; Abe O
Magn Reson Med Sci; 2019 Jan; 18(1):44-52. PubMed ID: 29769456
[TBL] [Abstract][Full Text] [Related]
10. Primary central nervous system lymphoma and atypical glioblastoma: differentiation using the initial area under the curve derived from dynamic contrast-enhanced MR and the apparent diffusion coefficient.
Choi YS; Lee HJ; Ahn SS; Chang JH; Kang SG; Kim EH; Kim SH; Lee SK
Eur Radiol; 2017 Apr; 27(4):1344-1351. PubMed ID: 27436023
[TBL] [Abstract][Full Text] [Related]
11. Discrimination between pituitary adenoma and craniopharyngioma using MRI-based image features and texture features.
Zhang Y; Chen C; Tian Z; Xu J
Jpn J Radiol; 2020 Dec; 38(12):1125-1134. PubMed ID: 32710133
[TBL] [Abstract][Full Text] [Related]
12. Differential Diagnostic Value of Texture Feature Analysis of Magnetic Resonance T2 Weighted Imaging between Glioblastoma and Primary Central Neural System Lymphoma.
Wang BT; Liu MX; Chen ZY
Chin Med Sci J; 2019 Mar; 34(1):10-17. PubMed ID: 30961775
[TBL] [Abstract][Full Text] [Related]
13. Primary central nervous system lymphoma and atypical glioblastoma: Differentiation using radiomics approach.
Suh HB; Choi YS; Bae S; Ahn SS; Chang JH; Kang SG; Kim EH; Kim SH; Lee SK
Eur Radiol; 2018 Sep; 28(9):3832-3839. PubMed ID: 29626238
[TBL] [Abstract][Full Text] [Related]
14. Radiomics features to distinguish glioblastoma from primary central nervous system lymphoma on multi-parametric MRI.
Kim Y; Cho HH; Kim ST; Park H; Nam D; Kong DS
Neuroradiology; 2018 Dec; 60(12):1297-1305. PubMed ID: 30232517
[TBL] [Abstract][Full Text] [Related]
15. New MR perfusion features in primary central nervous system lymphomas: pattern and prognostic impact.
Blasel S; Vorwerk R; Kiyose M; Mittelbronn M; Brunnberg U; Ackermann H; Voss M; Harter PN; Hattingen E
J Neurol; 2018 Mar; 265(3):647-658. PubMed ID: 29383512
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic Accuracy of T1-Weighted Dynamic Contrast-Enhanced-MRI and DWI-ADC for Differentiation of Glioblastoma and Primary CNS Lymphoma.
Lin X; Lee M; Buck O; Woo KM; Zhang Z; Hatzoglou V; Omuro A; Arevalo-Perez J; Thomas AA; Huse J; Peck K; Holodny AI; Young RJ
AJNR Am J Neuroradiol; 2017 Mar; 38(3):485-491. PubMed ID: 27932505
[TBL] [Abstract][Full Text] [Related]
17. Differentiating glioblastoma multiforme from cerebral lymphoma: application of advanced texture analysis of quantitative apparent diffusion coefficients.
Mehrnahad M; Rostami S; Kimia F; Kord R; Taheri MS; Rad HS; Haghighatkhah H; Moradi A; Kord A
Neuroradiol J; 2020 Oct; 33(5):428-436. PubMed ID: 32628089
[TBL] [Abstract][Full Text] [Related]
18. Feasibility of contrast-enhanced MRI derived textural features to predict overall survival in locally advanced breast cancer.
Chronaiou I; Giskeødegård GF; Goa PE; Teruel J; Hedayati R; Lundgren S; Huuse EM; Pickles MD; Gibbs P; Sitter B; Bathen TF
Acta Radiol; 2020 Jul; 61(7):875-884. PubMed ID: 31744303
[TBL] [Abstract][Full Text] [Related]
19. Tumor Heterogeneity in Lung Cancer: Assessment with Dynamic Contrast-enhanced MR Imaging.
Yoon SH; Park CM; Park SJ; Yoon JH; Hahn S; Goo JM
Radiology; 2016 Sep; 280(3):940-8. PubMed ID: 27031994
[TBL] [Abstract][Full Text] [Related]
20. Primary central nervous system lymphoma and glioblastoma differentiation based on conventional magnetic resonance imaging by high-throughput SIFT features.
Chen Y; Li Z; Wu G; Yu J; Wang Y; Lv X; Ju X; Chen Z
Int J Neurosci; 2018 Jul; 128(7):608-618. PubMed ID: 29183170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
